ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Hampshire » Pulmonary Disease

Top Pulmonary Disease Prescribers in New Hampshire

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MARIA DAVILA MD

Pulmonary Disease

4,857

$347K

199
164 are 65+

15%
patients receiving schedule two controlled substances

Avg: 0%

14%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 66%

$71
Average prescription price

Avg: $194

D. AKEY MD

Pulmonary Disease

1,145

$168K

125
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 66%

$147
Average prescription price

Avg: $194

WILLIAM STEPHAN M.D.

Pulmonary Disease

1,258

$275K

151
121 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 66%

$218
Average prescription price

Avg: $194

WILLIAM GOODMAN MD

Pulmonary Disease

1,038

$525K

139
96 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

70%
prescriptions for brand name drugs

Avg: 66%

$505
Average prescription price

Avg: $194

GREGORY SMULL MD

Pulmonary Disease

714

$151K

75
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

66%
prescriptions for brand name drugs

Avg: 66%

$212
Average prescription price

Avg: $194

EDUARDO VELEZ CALDERON MD

Pulmonary Disease

466

$91.7K

105
82 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

71%
prescriptions for brand name drugs

Avg: 66%

$197
Average prescription price

Avg: $194

PAUL DERANIAN MD

Pulmonary Disease

557

$115K

110
85 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

75%
prescriptions for brand name drugs

Avg: 66%

$207
Average prescription price

Avg: $194

JOSEPH HOU MD

Pulmonary Disease

881

$130K

183
127 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

64%
prescriptions for brand name drugs

Avg: 66%

$147
Average prescription price

Avg: $194

RICHARD HOLLISTER MD

Pulmonary Disease

741

$141K

134
92 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

80%
prescriptions for brand name drugs

Avg: 66%

$191
Average prescription price

Avg: $194

WAVERLY GREEN MD

Pulmonary Disease

1,655

$507K

265
188 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

71%
prescriptions for brand name drugs

Avg: 66%

$306
Average prescription price

Avg: $194

LISA TILLUCKDHARRY M.D.

Pulmonary Disease

661

$124K

120
92 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

75%
prescriptions for brand name drugs

Avg: 66%

$187
Average prescription price

Avg: $194

HENRY PARKER M.D.

Pulmonary Disease

390

$71.9K

41
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 66%

$184
Average prescription price

Avg: $194

NOEL WHEELER MD

Pulmonary Disease

484

$89K

92
61 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

74%
prescriptions for brand name drugs

Avg: 66%

$184
Average prescription price

Avg: $194

ROBERT BRETHAUER MD

Pulmonary Disease

909

$156K

121
84 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

66%
prescriptions for brand name drugs

Avg: 66%

$171
Average prescription price

Avg: $194

NAIM AOUN M.D.

Pulmonary Disease

569

$101K

113
84 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

73%
prescriptions for brand name drugs

Avg: 66%

$177
Average prescription price

Avg: $194

DONALD MAHLER M.D.

Pulmonary Disease

489

$303K

86
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

70%
prescriptions for brand name drugs

Avg: 66%

$619
Average prescription price

Avg: $194

JEFFREY NEWCOMER MD

Pulmonary Disease

939

$235K

178
147 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

88%
prescriptions for brand name drugs

Avg: 66%

$250
Average prescription price

Avg: $194

RICHARD ENELOW MD

Pulmonary Disease

521

$105K

73
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 66%

$202
Average prescription price

Avg: $194

HAROLD MANNING M.D.

Pulmonary Disease

309

$89.4K

48
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 66%

$289
Average prescription price

Avg: $194

LORENZO KLEIN MD

Pulmonary Disease

514

$66.5K

106
77 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 66%

$129
Average prescription price

Avg: $194

ELVIRA AGUILA MD

Pulmonary Disease

396

$89.8K

66
54 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

77%
prescriptions for brand name drugs

Avg: 66%

$227
Average prescription price

Avg: $194

MARK POHLMAN M.D.

Pulmonary Disease

487

$64.9K

101
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 66%

$133
Average prescription price

Avg: $194

STEPHEN IMGRUND MD

Pulmonary Disease

671

$87.4K

85
61 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 66%

$130
Average prescription price

Avg: $194

STEPHEN ROWE MD

Pulmonary Disease

829

$168K

134
113 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

74%
prescriptions for brand name drugs

Avg: 66%

$203
Average prescription price

Avg: $194

PETER CORRIGAN MD

Pulmonary Disease

1,059

$211K

167
125 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

67%
prescriptions for brand name drugs

Avg: 66%

$199
Average prescription price

Avg: $194

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank